Xiaowei Liu

3.2k total citations · 3 hit papers
63 papers, 2.3k citations indexed

About

Xiaowei Liu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xiaowei Liu has authored 63 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 16 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Xiaowei Liu's work include RNA Interference and Gene Delivery (8 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Advanced biosensing and bioanalysis techniques (8 papers). Xiaowei Liu is often cited by papers focused on RNA Interference and Gene Delivery (8 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Advanced biosensing and bioanalysis techniques (8 papers). Xiaowei Liu collaborates with scholars based in China, United States and United Kingdom. Xiaowei Liu's co-authors include Hubing Shi, Hao Yan, Jing Jing, Xing‐Jie Liang, Dengli Qiu, Lin Lin, Jeanette Nangreave, Baoquan Ding, Guozhang Zou and Qiao Jiang and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and ACS Nano.

In The Last Decade

Xiaowei Liu

60 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

DNA Origami as a Carrier for Circumvention of Drug Resistance

2012 619 citations Xiaowei Liu et al. profile →
Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance

2023 217 citations Xiaowei Liu, Jinen Song et al. Cancer Cell profile →
Artificial intelligence-based multi-omics analysis fuels cancer precision medicine

2022 202 citations Xiujing He, Xiaowei Liu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaowei Liu China	20	1.6k	391	388	274	251	63	2.3k
Yuwen Zhang China	28	1.7k 1.1×	202 0.5×	344 0.9×	267 1.0×	430 1.7×	74	2.5k
Jing Song China	27	1.9k 1.2×	243 0.6×	671 1.7×	350 1.3×	464 1.8×	97	2.8k
María Virtudes Céspedes Spain	29	1.2k 0.7×	163 0.4×	704 1.8×	387 1.4×	358 1.4×	65	2.2k
Yan Fang China	24	1.1k 0.7×	424 1.1×	329 0.8×	350 1.3×	507 2.0×	102	2.3k
Shelia D. Thomas United States	21	2.5k 1.6×	251 0.6×	341 0.9×	158 0.6×	396 1.6×	31	3.0k
Kenji Yokoi United States	29	1.5k 0.9×	624 1.6×	730 1.9×	284 1.0×	456 1.8×	90	2.8k
Marcel H.J. Ruiters Netherlands	26	1.5k 1.0×	131 0.3×	383 1.0×	316 1.2×	236 0.9×	62	2.3k
Ronggui Hu China	22	1.1k 0.7×	370 0.9×	255 0.7×	172 0.6×	222 0.9×	56	2.0k
Byung Il Lee South Korea	27	1.1k 0.7×	239 0.6×	194 0.5×	140 0.5×	125 0.5×	86	2.0k
Yu-Chieh Wang United States	22	2.0k 1.3×	219 0.6×	431 1.1×	279 1.0×	589 2.3×	48	2.7k

Countries citing papers authored by Xiaowei Liu

Since Specialization

Citations

This map shows the geographic impact of Xiaowei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowei Liu more than expected).

Fields of papers citing papers by Xiaowei Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaowei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowei Liu. The network helps show where Xiaowei Liu may publish in the future.

Co-authorship network of co-authors of Xiaowei Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaowei Liu. A scholar is included among the top collaborators of Xiaowei Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaowei Liu. Xiaowei Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Xiaowei, Jinen Song, Huihui Li, et al.. (2025). Single-cell transcriptional dissection illuminates an evolution of immunosuppressive microenvironment during pancreatic ductal adenocarcinoma metastasis. Signal Transduction and Targeted Therapy. 10(1). 182–182. 2 indexed citations

Zhou, Yao, Xiaowei Liu, Genpeng Li, et al.. (2025). Galectin-9-driven immunosuppressive macrophage population shapes the lymph node metastatic microenvironment. British Journal of Cancer. 134(1). 45–59.

Chai, Jiani, et al.. (2024). Clinical validation of the Ion Torrent Oncomine Myeloid Assay GX v2 on the Genexus Integrated Sequencer as a stand-alone assay for single-nucleotide variants, insertions/deletions, and fusion genes: Challenges, performance, and perspectives. American Journal of Clinical Pathology. 162(5). 480–491.

Liu, Xiaowei, et al.. (2024). Inhibition of Mettl3 ameliorates osteoblastic senescence by mitigating m6A modifications on Slc1a5 via Igf2bp2-dependent mechanisms. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(7). 167273–167273. 7 indexed citations

Liu, Wenjing, et al.. (2024). Multi-omics analysis for mechanistic understanding of microbial-mediated synthesis of silver nanoparticles. Chemical Engineering Journal. 497. 154410–154410. 4 indexed citations

Zhu, Wanling, Xiaowei Liu, Lei Yang, et al.. (2023). Ferroptosis and tumor immunity: In perspective of the major cell components in the tumor microenvironment. European Journal of Pharmacology. 961. 176124–176124. 11 indexed citations

Yang, Suleixin, Xiaowei Liu, Xiuqi Liang, et al.. (2023). Programmable double-unlock nanocomplex self-supplies phenylalanine ammonia-lyase for precise phenylalanine deprivation of tumors. Chinese Chemical Letters. 35(8). 109275–109275. 3 indexed citations

Lin, Yan, et al.. (2023). A computational model to identify fertility-related proteins using sequence information. Frontiers of Computer Science. 18(1). 4 indexed citations

Liu, Xiaowei, Jinen Song, Hao Zhang, et al.. (2023). Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance. Cancer Cell. 41(2). 272–287.e9. 217 indexed citations breakdown →

10.

Guo, Xinyu, Shi Chen, Xueyan Wang, & Xiaowei Liu. (2023). Immune-related pulmonary toxicities of checkpoint inhibitors in non-small cell lung cancer: Diagnosis, mechanism, and treatment strategies. Frontiers in Immunology. 14. 1138483–1138483. 15 indexed citations

11.

Liu, Xiaowei, Jinen Song, Xinyu Liu, et al.. (2023). Protocol for identifying immune checkpoint on circulating tumor cells of human pancreatic ductal adenocarcinoma by single-cell RNA sequencing. STAR Protocols. 4(3). 102539–102539. 4 indexed citations

12.

Zhao, Yujie, Xian Jiang, Xu Liu, et al.. (2022). Application of photo-responsive metal-organic framework in cancer therapy and bioimaging. Frontiers in Bioengineering and Biotechnology. 10. 1031986–1031986. 26 indexed citations

13.

Yu, Jing, Xi Wu, Jinen Song, et al.. (2022). Loss of MHC-I antigen presentation correlated with immune checkpoint blockade tolerance in MAPK inhibitor-resistant melanoma. Frontiers in Pharmacology. 13. 928226–928226. 16 indexed citations

14.

Su, Wei, Xiaowei Liu, Hasan Zulfiqar, et al.. (2022). iRNA-ac4C: A novel computational method for effectively detecting N4-acetylcytidine sites in human mRNA. International Journal of Biological Macromolecules. 227. 1174–1181. 35 indexed citations

15.

Wang, Xueyan, Jing Yu, Xiaowei Liu, et al.. (2022). PSMG2-controlled proteasome-autophagy balance mediates the tolerance for MEK-targeted therapy in triple-negative breast cancer. Cell Reports Medicine. 3(9). 100741–100741. 20 indexed citations

16.

Wang, Lulu & Xiaowei Liu. (2022). Comprehensive Analysis of the Expression and Prognosis for the DREAM Complex in Human Cancers. Frontiers in Genetics. 13. 814725–814725. 6 indexed citations

17.

Xu, Guangchao, Ya Luo, Wenshuang Wu, et al.. (2021). The Evolution of Acquired Resistance to BRAFV600E kinase inhibitor Is Sustained by IGF1-Driven Tumor Vascular Remodeling. Journal of Investigative Dermatology. 142(2). 445–458. 15 indexed citations

18.

Han, Gui‐Mei, Yan Huang, Hongxin Jiang, et al.. (2020). Ultrasensitive ratiometric detection of Pb2+ using DNA tetrahedron-mediated hyperbranched hybridization chain reaction. Analytica Chimica Acta. 1147. 170–177. 30 indexed citations

19.

Luo, Xin, Chunhui Jin, Zhenhe Zhou, et al.. (2016). Association study of DISC1 genetic variants with the risk of schizophrenia. Psychiatric Genetics. 26(3). 132–135. 7 indexed citations

20.

Liu, Xiaowei, Bo Wu, Jarosław Szary, Eric M. Kofoed, & Fred Schaufele. (2007). Functional Sequestration of Transcription Factor Activity by Repetitive DNA. Journal of Biological Chemistry. 282(29). 20868–20876. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact